G8946
HCPCSMibm but no dx of breast ca
Official HCPCS Level II long descriptor
Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)
HCPCS Level II code G8946 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Mibm but no dx of breast ca
Added to HCPCS: 2013-01-01
Nearby codes in G8
- G8923Lvef <= 40% or lvsd
- G8924Spir res doc fev1/fvc<70%
- G8934Lvef <=40% or dep lv sys fcn
- G8935Rx ace or arb therapy
- G8936Pt not eligible ace/arb
- G8937No rx ace/arb therapy
- G8942Doc fcn/care plan w/30 days
- G8944Ajcc mel cnr stg 0 - iic
- G8950Pre-htn or htn doc, f/u indc
- G8952Pre-htn/htn, no f/u, not gvn
- G8955Most recent assess vol mgmt
- G8956Pt rcv hedia outpt dyls fac
- G8958Assess vol mgmt not doc
- G8961Csit lowrisk surg pts preop
- G8962Csit on pt any reas 30 days
- G8967Warf or other fda drug presc
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.